Healthcare

TechVision's Medical Devices and Imaging technology cluster's flagship research service profiles ten cutting-edge medical technologies that are expected to have a huge impact on the healthcare industry in the next two years. Each of technologies that have been profiled here represent billions of dollars in market potential, and have a rich track re...

Readers of Lab Manager Magazine were invited to participate in an online survey in July 2016. To qualify for survey participation, readers had to play a role in their laboratory’s purchasing process, be familiar with their laboratory’s product budgets, and represent a laboratory that either uses or plans to use products in 1 or more of the 7 sp...

The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...

Immuno-oncology is based on the premise that tumors escape detection by the immune system, contributing to their growth and progression. Checkpoint inhibitor pathways act as the checks and balances that allow T-cells to recognize foreign substances or tumors. This global study looks at the immune-oncology therapeutics pipeline for checkpoint inhibi...

Readers of the Lab Manager Magazine were invited to participate in an online survey in August 2015. To qualify, readers were required to play a role in their lab’s purchasing process, be familiar with their labs’ product budgets, and represent a lab that either uses or plans to use products in one or more of the 7 specified categories (instrume...